China Pharma Holdings, Inc.
CPHI
$1.75
-$0.035-1.97%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.31% | -53.84% | -52.50% | -40.97% | -4.07% |
| Total Depreciation and Amortization | -21.15% | -4.92% | 6.25% | 6.48% | 5.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 330.15% | 2,585.25% | 565.14% | 4,245.24% | 616.23% |
| Change in Net Operating Assets | 123.84% | 369.84% | 140.40% | 397.12% | 461.13% |
| Cash from Operations | -66.74% | 33.33% | -684.47% | 137.13% | 118.37% |
| Capital Expenditure | -43.26% | -233.91% | -215.27% | 82.42% | 80.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -200.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -452.30% | -2,437.39% | -215.27% | 39.26% | 80.41% |
| Total Debt Issued | -50.89% | -67.17% | 46.70% | 40.59% | -5.39% |
| Total Debt Repaid | 61.77% | 66.93% | 10.20% | -62.19% | 28.38% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.45% | -- | -- | -- | -- |
| Cash from Financing | 88.70% | -62.52% | 108.10% | -246.87% | 55.11% |
| Foreign Exchange rate Adjustments | -1,020.69% | -307.84% | 430.82% | 124.67% | 97.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.91% | -31.50% | 9.10% | 87.90% | 87.13% |